Deetee
Illuminator
- Joined
- Jul 8, 2003
- Messages
- 3,789
This week's BMJ features some articles on SCAM following on from the recent PoWales/Smallwood report, including an editorial which is rather ambivalent, I think
http://bmj.bmjjournals.com/cgi/content/full/331/7521/856
Also http://bmj.bmjjournals.com/cgi/content/full/331/7521/880
http://bmj.bmjjournals.com/cgi/content/full/331/7521/0-h
There is also an ongoing rapid response discussion about CAM here:
http://bmj.bmjjournals.com/cgi/eletters/331/7520/795-a
Enjoy.
Respond, if you wish - (the altmedders certainly will)
http://bmj.bmjjournals.com/cgi/content/full/331/7521/856
Nothing about establishing whether the things work in the first place I see....Or perhaps they recognise they don't? And NICE should stick to clinical effectiveness, not cost effectiveness anyway, so I don't see why SCAM cannot be reviewed..Despite its limitations and the likelihood of bias in its conclusions, we believe that the Smallwood report fulfills a useful political function. It should promote more investment in research on the cost effectiveness of complementary and alternative treatments. Nevertheless, the report's principal recommendation—that NICE (the National Institute for Health and Clinical Excellence) carries out a full assessment of the cost effectiveness of these therapies—is ill advised.
Uncertain evidence of effectiveness does not preclude a positive recommendation in a guideline, and original modelling of cost effectiveness can be part of guideline development
Also http://bmj.bmjjournals.com/cgi/content/full/331/7521/880
http://bmj.bmjjournals.com/cgi/content/full/331/7521/0-h
There is also an ongoing rapid response discussion about CAM here:
http://bmj.bmjjournals.com/cgi/eletters/331/7520/795-a
Enjoy.
Respond, if you wish - (the altmedders certainly will)
